Cite

HARVARD Citation

    Place, A. et al. (2018). Accelerating drug development in pediatric cancer: a novel Phase I study design of venetoclax in relapsed/refractory malignancies. Future oncology. pp. 2115-2129. [Online]. 
  
Back to record